Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for IN VITRO DIAGNOSTIC USE in the quantitati...
FDA Device Recall #Z-0931-2017 — Class III — July 20, 2016
Recall Summary
| Recall Number | Z-0931-2017 |
| Classification | Class III — Low risk |
| Date Initiated | July 20, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Sterling Diagnostics, Inc. |
| Location | Sterling Heights, MI |
| Product Type | Devices |
| Quantity | 182 |
Product Description
Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for IN VITRO DIAGNOSTIC USE in the quantitative determination of analytes. These are CONSUMABLES - a customer buys another when kit is consumed.
Reason for Recall
Sterling Diagnostics, Inc. initiated a recall on 7/20/2016 for multiple diagnostic kits due to a recision of the previously extended expiration dates for the kits.
Distribution Pattern
Domestic: MI Foreign: Phillipines VA/DOD: None
Lot / Code Information
Creatinine/Endpoint [Modified Heinegard-Tiderstrom], CAT No. 2167-O, Lot No. 16751, Expriry: 5/18, Manufactured: 06/02/15
Other Recalls from Sterling Diagnostics, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0934-2017 | Class III | Sterling Diagnostics, Inc.Colorimetric SGOT for... | Jul 20, 2016 |
| Z-0929-2017 | Class III | Enzymatic Cholesterol (Trinder/COD-CEH) for IN ... | Jul 20, 2016 |
| Z-0937-2017 | Class III | Sterling Diagnostics, Inc., Enzymatic Uric Acid... | Jul 20, 2016 |
| Z-0932-2017 | Class III | Sterling Diagnostics, Inc., Enzymatic Glucose ... | Jul 20, 2016 |
| Z-0930-2017 | Class III | Sterling Diagnostics, Inc., HDL Cholesterol (PE... | Jul 20, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.